Zhang Yi, Zhang Cuihua
Yi Zhang, Cuihua Zhang, Department of Internal Medicine, Medical Pharmacology and Physiology and Nutritional Sciences, Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO 65211, United States.
World J Cardiol. 2010 Nov 26;2(11):357-64. doi: 10.4330/wjc.v2.i11.357.
Dendritic cells (DCs) are potent antigen-presenting cells that bridge innate and adaptive immune responses. Recent work has elucidated the DC life cycle, including several important stages such as maturation, migration and homeostasis, as well as DC classification and subsets/locations, which provided etiological insights on the role of DCs in disease processes. DCs have a close relationship to endothelial cells and they interact with each other to maintain immunity. DCs are deposited in the atherosclerotic plaque and contribute to the pathogenesis of atherosclerosis. In addition, the necrotic cardiac cells induced by ischemia activate DCs by Toll-like receptors, which initiate innate and adaptive immune responses to renal, hepatic and cardiac ischemia reperfusion injury (IRI). Furthermore, DCs are involved in the acute/chronic rejection of solid organ transplantation and mediate transplant tolerance as well. Advancing our knowledge of the biology of DCs will aid development of new approaches to treat many cardiovascular diseases, including atherosclerosis, cardiac IRI and transplantation.
树突状细胞(DCs)是强大的抗原呈递细胞,可连接先天性和适应性免疫反应。最近的研究阐明了DC的生命周期,包括成熟、迁移和稳态等几个重要阶段,以及DC的分类和亚群/定位,这为DC在疾病过程中的作用提供了病因学见解。DC与内皮细胞关系密切,它们相互作用以维持免疫。DC沉积在动脉粥样硬化斑块中,并促进动脉粥样硬化的发病机制。此外,缺血诱导的坏死心肌细胞通过Toll样受体激活DC,从而引发对肾、肝和心脏缺血再灌注损伤(IRI)的先天性和适应性免疫反应。此外,DC还参与实体器官移植的急性/慢性排斥反应,并介导移植耐受。加深我们对DC生物学的了解将有助于开发治疗许多心血管疾病的新方法,包括动脉粥样硬化、心脏IRI和移植。